- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Microalbuminuria Due to Type 2 Diabetes Mellitus in Switzerland
Total 155 results
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
Cytos Biotechnology AGCompletedType 2 Diabetes MellitusGermany, Switzerland
-
University Hospital, Basel, SwitzerlandUniversity of Basel; Solothurner Spitäler AGCompletedDiabetes Mellitus Type 2Switzerland
-
University Hospital, Basel, SwitzerlandSolidarMed; Swiss Agency for Development and Cooperation (SDC); World Diabetes...RecruitingType 2 Diabetes Mellitus (T2D)Lesotho, Switzerland
-
Janssen Research & Development, LLCCompleted
-
Cabinet MedicalTrialance SCCLCompletedType 2 Diabetes Mellitus | Overweight and ObesitySwitzerland
-
University Hospital, Basel, SwitzerlandRecruitingInflammation | Metabolic Disease | Diabetes Mellitus Type 2 in Obese | Glucose Metabolism Disorders (Including Diabetes Mellitus)Switzerland
-
XOMA (US) LLCCompleted
-
University of ZurichUnknownPrediabetes / Type 2 DiabetesSwitzerland
-
Kantonsspital Baselland BruderholzCompletedDiabetes Mellitus Type 2Switzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital Schleswig-HolsteinCompletedType 2 Diabetes Mellitus | Bone FracturesSwitzerland
-
University Hospital, GenevaMaastricht University Medical Center; Swiss Federal Institute of Technology; Ecole...Completed
-
Carole ClairTerminatedSmoking Cessation | Diabetes Type 2Switzerland
-
University of ZurichSteno Diabetes Center CopenhagenCompletedType 2 DiabetesSwitzerland, Denmark
-
University of ZurichCompletedType 2 DiabetesSwitzerland
-
University Hospital, Basel, SwitzerlandMcGill UniversityCompletedInsulin Resistance | Diabetes Mellitus Type 2 | Other Functional Disturbances Following Cardiac SurgerySwitzerland
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Pediatric Clinical Research PlatformUniversity Hospital, Geneva; University of Geneva, SwitzerlandRecruitingGenetic Predisposition to Disease | Type 1 Diabetes MellitusSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
University Hospital, Basel, SwitzerlandOlatec Therapeutics LLC; State Secretariat for Education Research and Innovation... and other collaboratorsNot yet recruitingDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
University Hospital TuebingenMedical University of Vienna; University of Bern; CenTrial GmbHTerminatedObesity | DiabetesAustria, Germany, Switzerland
-
University Hospital Inselspital, BerneTerminatedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Berner Klinik MontanaCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany, Switzerland
-
University of ZurichEuropean Foundation for the Study of DiabetesCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Denmark, Greece, Germany, Switzerland, Italy
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Estonia, Bulgaria, Romania, Puerto Rico, Switzerland, United Kingdom
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Germany, United Kingdom, Sweden, Switzerland
-
University of BaselSwiss National Science FoundationCompletedObesity | Diabetes Mellitus, Type 2 | OverweightSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Switzerland, Denmark, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
-
University of CambridgeUniversity Hospital Inselspital, BerneCompletedEnd Stage Renal Disease | Type 2 DiabetesUnited Kingdom, Switzerland
-
Spiden AGDCB Research AGCompletedType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Cantonal Hospital of St. GallenMedical University of Graz; European Foundation for the Study of DiabetesCompletedDiabetes Mellitus, Type 2 | Bariatric Surgery CandidateAustria, Switzerland
-
University Hospital Inselspital, BerneCompletedDiabetes Complications | Type 1 Diabetes MellitusSwitzerland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSouth Africa, Germany, Hungary, Romania, Slovakia, Switzerland, Ukraine
-
Antea FoundationAbbott Diabetes CareActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes | Cancer | Diabetes Mellitus, Type 1 | Advanced Cancer | Palliative Care | Terminal Illness | End Stage Cancer | Terminal CancerIsrael, Italy, Switzerland
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
University Hospital, GenevaSwiss National Science FoundationCompletedType 1 Diabetes MellitusSwitzerland